The Patent Finder

Bionevia Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Bionevia Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 5 of 5 · Back to Bionevia Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,697,735Solid forms of epalrestat
Lapsed on the fee record
Ended Apr 15, 2026 · USPTO record
Lapsed on the fee recordEnded Apr 15, 2026USPTO record
US 9,611,234Choline cocrystal of epalrestat
Lapsed on the fee record
Ended Apr 4, 2025 · USPTO record
Lapsed on the fee recordEnded Apr 4, 2025USPTO record
US 9,566,269Modified release compositions of epalrestat or a derivative thereof and methods for using the same
Lapsed on the fee record
Ended Feb 14, 2025 · USPTO record
Lapsed on the fee recordEnded Feb 14, 2025USPTO record
US 9,447,056Solid forms of epalrestat
Lapsed on the fee record
Ended Sep 20, 2024 · USPTO record
Lapsed on the fee recordEnded Sep 20, 2024USPTO record
US 10,464,912Choline cocrystal of epalrestat
Lapsed on the fee record
Ended Nov 5, 2023 · USPTO record
Lapsed on the fee recordEnded Nov 5, 2023USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited